Hyperprolactinemia and cancer risk: a Swedish population-based cohort study
Objective: Prolactin (PRL) promotes cell proliferation, and PRL receptor expression is elevated in various cancer types. However, only a few studies have examined cancer risk in patients with hyperprolactinemia (HPL). The aim of this study was to investigate cancer risk in a nationwide cohort of pat...
Saved in:
| Main Authors: | Christos Himonakos, Louise Emilsson, Sophie Bensing, Katarina Berinder |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2025-06-01
|
| Series: | Endocrine Connections |
| Subjects: | |
| Online Access: | https://ec.bioscientifica.com/view/journals/ec/14/6/EC-25-0108.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Hyperprolactinemia in Clinical Practice
by: Bayar Ahmed Qasim, et al.
Published: (2023-12-01) -
Prolactinoma or leiomyoma-associated hyperprolactinemia—this is the question, a case report and review of the literature
by: Ralitsa Robeva, et al.
Published: (2022-09-01) -
Hyperprolactinemia caused by extra-pituitary prolactin secretion: a systematic review
by: Yixin Lu, et al.
Published: (2025-07-01) -
Management of prolactinoma during pregnancy and postpartum
by: Om J Lakhani, et al.
Published: (2015-01-01) -
A case of hyperprolactinemia in patient with metastatic breast cancer: clinical case presentation
by: L. K. Dzeranova, et al.
Published: (2014-07-01)